` Comparison: RN3N vs ABBV - Alpha Spread

A
RN3N
vs
ABBV

Over the past 12 months, RN3N has underperformed ABBV, delivering a return of 0% compared to the ABBV's +25% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RN3N
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

A
RN3N Intrinsic Value
Not Available
ABBV Intrinsic Value
220.33 USD
Fairly Valued
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
A
Arena Pharmaceuticals Inc
F:RN3N
90.5 EUR
Abbvie Inc
NYSE:ABBV
219.88 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RN3N, ABBV

RN3N
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
A
Arena Pharmaceuticals Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
RN3N, ABBV

RN3N
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
A
Arena Pharmaceuticals Inc
F:RN3N
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

RN3N
0%
ABBV
71.2%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

Operating Margin

RN3N
-1 188 120.3%
ABBV
33.1%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

Net Margin

RN3N
-1 342 164.7%
ABBV
3.9%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

FCF Margin

RN3N
-1 138 772.4%
ABBV
33%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

ROE

RN3N
-82.7%
ABBV
138.5%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

ROA

RN3N
-73.4%
ABBV
1.7%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

ROIC

RN3N
-434%
ABBV
28.4%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

ROCE

RN3N
-69.3%
ABBV
20.2%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Arena Pharmaceuticals Inc
Abbvie Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
RN3N, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RN3N, ABBV

Loading
RN3N
ABBV
Difference
www.alphaspread.com

Performance By Year
RN3N, ABBV

Loading
RN3N
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RN3N to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account